Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Medtronic
Farmers Insurance
Colorcon
Queensland Health
AstraZeneca
US Army
Merck
Daiichi Sankyo

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,914,122

« Back to Dashboard

Summary for Patent: 5,914,122
Title: Stable budesonide solutions, method of preparing them and use of these solutions as enema preparations and pharmaceutical foams
Abstract:A stable budesonide solution with a pH not exceeding 6.0 in which the budesonide is dissolved in a solvent which may be water, an alcohol such as ethanol, isopropanol or propylene glycol, or a water/alcohol mixture. The solution preferably also contains a stabilizer such as sodium ethylenediaminetetraacetic acid, cyclodextrins or mixtures thereof. The stable budesonide solution is useful as the active ingredient in a rectal enema or a rectal foam.
Inventor(s): Otterbeck; Norbert (Uberlingen, DE), Kuhn; Reimund (Freiamt, DE)
Assignee: Dr. Falk Pharma GmbH (Freiburg, DE)
Application Number:08/860,136
Patent Claim Types:
see list of patent claims
Formulation; Process;

Drugs Protected by US Patent 5,914,122

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,914,122

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany44 46 891Dec 27, 1994

International Patents Family Members for US Patent 5,914,122

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 168556 ➤ Try a Free Trial
Canada 2205305 ➤ Try a Free Trial
Germany 4446891 ➤ Try a Free Trial
Germany 59502928 ➤ Try a Free Trial
Denmark 0794767 ➤ Try a Free Trial
European Patent Office 0794767 ➤ Try a Free Trial
Spain 2120247 ➤ Try a Free Trial
Greece 3027632 ➤ Try a Free Trial
Japan 3421348 ➤ Try a Free Trial
Japan H10511364 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Farmers Insurance
QuintilesIMS
Covington
Chinese Patent Office
Cantor Fitzgerald
Dow
Medtronic
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot